Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000464919 | SCV000517783 | likely benign | not provided | 2021-09-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28620870, 27572814) |
Mayo Clinic Laboratories, |
RCV000464919 | SCV001714097 | uncertain significance | not provided | 2023-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521138 | SCV001730411 | benign | Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000464919 | SCV004154533 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | QARS1: BP4 |
Prevention |
RCV003932582 | SCV004753814 | likely benign | QARS1-related disorder | 2019-11-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |